Seilern Investment Management’s Edwards Lifesciences EW Stock Holding History

Seilern Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.3M	Sell	600,231 -89,960	-13%	-$7.54M	6.84%	4
2026 Q1	$55.3M	Sell	690,191 -233,069	-25%	-$19.2M	6.59%	6
2025 Q4	$78.7M	Sell	923,260 -132,514	-13%	-$10.9M	6.1%	6
2025 Q3	$82.1M	Sell	1,055,774 -183,101	-15%	-$14.3M	5.93%	9
2025 Q2	$96.9M	Sell	1,238,875 -130,584	-10%	-$9.74M	6.39%	5
2025 Q1	$99.3M	Sell	1,369,459 -109,530	-7%	-$7.84M	6.49%	5
2024 Q4	$109M	Buy	+1,478,989	New	+$104M	6.24%	8

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Seilern Investment Management's EW Position: Q2 2026 in Review

Seilern Investment Management reduced its Edwards Lifesciences (EW) stake by 13% in Q2 2026, selling an estimated $7.54M and leaving 600,231 shares worth $54.3M. The position accounts for 6.84% of the portfolio, ranked #4.

Seilern Investment Management first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $109M in Q4 2024. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Seilern Investment Management held 600,231 shares of Edwards Lifesciences worth $54.3M as of Q2 2026.
Seilern Investment Management sold 89,960 Edwards Lifesciences shares in Q2 2026, an estimated $7.54M.
Edwards Lifesciences made up 6.84% of Seilern Investment Management's portfolio in Q2 2026, its #4 holding.
Seilern Investment Management first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
Seilern Investment Management's Edwards Lifesciences position peaked at $109M in Q4 2024.
372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Seilern Investment Management's 13F filing for Q2 2026, filed 8 Jul 2026.